134 related articles for article (PubMed ID: 3334581)
21. Emergence of tobramycin-resistant S. epidermidis possessing aminoglycoside modifying enzymes and bacteremic superinfection during empiric therapy of febrile neutropenic episodes.
Riben PD; Horsman GB; Rayner E; Irvine-Meek J; Urias B; Albritton WL; deSaxe MJ; Ronald AR; Louie TJ
Clin Invest Med; 1985; 8(4):272-85. PubMed ID: 3907919
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of therapeutic efficacy of ureidopenicillins in comparison to sisomicin and cephalotin in experimental infections of rabbits.
Dzierzanowska D; Klosinska E; Roszkowski W; Patzer J; Jeljaszewicz J
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Sep; 250(3):312-21. PubMed ID: 6458186
[TBL] [Abstract][Full Text] [Related]
23. A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients.
Feld R; Louie TJ; Mandell L; Bow EJ; Robson HG; Chow A; Belch A; Miedzinski L; Rachlis A; Pater J
Arch Intern Med; 1985 Jun; 145(6):1083-8. PubMed ID: 3890789
[TBL] [Abstract][Full Text] [Related]
24. Combination therapy with ticarcillin and sulfamethoxazole-trimethoprim for infections in patients with cancer.
Keating MJ; Lawson R; Grose W; Bodey GP
Arch Intern Med; 1981 Jun; 141(7):926-30. PubMed ID: 7235813
[TBL] [Abstract][Full Text] [Related]
25. [Role of azlocillin in the treatment of immunocompromised patients. Results of the EORTC (European Organization for Research on the Treatment of Cancer) study)].
Jacquillat C; Khayat D; Maral J
Presse Med; 1984 Mar; 13(13):838-40. PubMed ID: 6324161
[TBL] [Abstract][Full Text] [Related]
26. Infection in neutropenic cancer patients: three decades of progress.
Schimpff SC
Support Care Cancer; 1997 Sep; 5(5):343-5. PubMed ID: 9376973
[No Abstract] [Full Text] [Related]
27. Randomised study of ticarcillin, cefamandole with or without tobramycin in febrile, neutropenic patients with solid tumors.
Page JP; Levi JA; Woods RL; Chan WK; Bell DR; Aroney RS
Med Pediatr Oncol; 1987; 15(1):7-13. PubMed ID: 3561330
[TBL] [Abstract][Full Text] [Related]
28. Prospective randomly controlled trial of three antibiotic combinations for empirical therapy of suspected sepsis in neutropenic cancer patients.
Gaya H; Klastersky J; Schimpff SC; Fière D; Widmaier S; Nagel G
Eur J Cancer (1965); 1975 Aug; 11suppl():5-8. PubMed ID: 767119
[No Abstract] [Full Text] [Related]
29. Comparative efficacies of piperacillin, azlocillin, ticarcillin, aztreonam, and tobramycin against experimental Pseudomonas aeruginosa pneumonia.
Schiff JB; Pennington JE
Antimicrob Agents Chemother; 1984 Jan; 25(1):49-52. PubMed ID: 6538397
[TBL] [Abstract][Full Text] [Related]
30. A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.
Hou F; Li J; Gao L; Chen Y
Chin Med J (Engl); 1998 Nov; 111(11):1039-43. PubMed ID: 11189212
[TBL] [Abstract][Full Text] [Related]
31. Monotherapy with pefloxacin in neutropenic febrile patients.
Daniels-Bosman MS; Beun GD; Debrus-Palmans LL; Blijham GH
Chemioterapia; 1987 Jun; 6(2 Suppl):410. PubMed ID: 3509459
[No Abstract] [Full Text] [Related]
32. Impact of dosing intervals on activity of gentamicin and ticarcillin against Pseudomonas aeruginosa in granulocytopenic mice.
Gerber AU; Craig WA; Brugger HP; Feller C; Vastola AP; Brandel J
J Infect Dis; 1983 May; 147(5):910-7. PubMed ID: 6842025
[TBL] [Abstract][Full Text] [Related]
33. [Ticarcillin sodium in the field of orodental surgery].
Tsuji T; Hasui Y; Hiromi A; Kawashima J; Ueno Y
Shikai Tenbo; 1985 Jul; 66(1):225-30. PubMed ID: 3865425
[No Abstract] [Full Text] [Related]
34. A bullous lesion in a neutropenic adolescent.
Doughty CB; Cruz AT; Kaplan SL
Pediatr Emerg Care; 2009 Feb; 25(2):100-1. PubMed ID: 19225377
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo action of mezlocillin and azlocillin combined with sisomicin.
Dzierzanowska D; Jeljaszewicz J
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Sep; 255(2-3):346-55. PubMed ID: 6417945
[TBL] [Abstract][Full Text] [Related]
36. [Gentamicin: clinical and laboratory observations in infants and children].
Panero C
Minerva Med; 1967 Nov; 58(95 Suppl):4227-9. PubMed ID: 4866799
[No Abstract] [Full Text] [Related]
37. In vitro evaluation of newer beta-lactam antibiotics against gram negative bacilli isolated from neutropenic patients.
Ebenezer S; Lalitha MK; Jesudason MV; Chandy M
Indian J Cancer; 1994 Mar; 31(1):23-6. PubMed ID: 8063332
[TBL] [Abstract][Full Text] [Related]
38. Comparison of azlocillin and ticarcillin in the treatment of urinary tract infection.
Reed WP; Palmer DL
J Antimicrob Chemother; 1983 May; 11 Suppl B():189-93. PubMed ID: 6619028
[TBL] [Abstract][Full Text] [Related]
39. Gram negative infections in burns and their chemotherapy.
Williams HB
Int Z Klin Pharmakol Ther Toxikol; 1969 Jan; 2(1):3-10. PubMed ID: 4307964
[No Abstract] [Full Text] [Related]
40. Evaluation of azlocillin-amikacin combination for empirical therapy of infection in febrile neutropenic patients.
D'Antonio D; di Girolamo A; Iacone A; Fioritoni G; Angelini A; Dragani A; Betti S; Dell'Isola M; Piccolomini R
J Chemother; 1989 Dec; 1(6):407-12. PubMed ID: 2693624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
